Dermatology News: 2007.19

• 2007.19(10) Cost-effectiveness of grass allergen tablet (GRAZAX®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective
  The prevalence of allergic rhinoconjunctivitis has increased dramatically. Seventeen million people in the United Kingdom, Germany, the Netherlands, Sweden, Denmark, Norway and Finland suffer from grass pollen induced allergic rhinitis.   |   Read more ...



• 2007.19(9) The association between infant feeding practices and subsequent atopy among children with a family history of asthma
  Although longer duration of breastfeeding and later introduction of solid foods are both recommended for the prevention of asthma and allergic disease, evidence to support these recommendations is controversial...   |   Read more ...



• 2007.19(8) Food anaphylaxis
  The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded...   |   Read more ...



• 2007.19(7) BSACI guidelines for the management of chronic urticaria and angio-oedema
  This guidance for the management of patients with chronic urticaria and angio-oedema has been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI)...   |   Read more ...



• 2007.19(6) The temporal sequence of allergic sensitization and onset of infantile eczema
  Eczema is commonly associated with sensitization in infants, but the causative role of sensitization in the development of eczema has been questioned...   |   Read more ...



• 2007.19(5) Management of actinic cheilitis using diclofenac 3% gel: a report of six cases
  Actinic cheilitis is a frequent manifestation of actinic dysplasia and requires early therapy to prevent its progression into invasive squamous cell carcinoma (SCC). Several therapies are used, ranging from unspecific lesion-adapted destructive techniques...   |   Read more ...



• 2007.19(4) Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases
  Non-melanoma skin cancer (NMSC) represents a significant cause of morbidity in organ transplant patients; the relative risk of squamous cell carcinoma and actinic keratosis (AK) is 100 and 250 times higher, respectively, compared with immunocompetent patients...   |   Read more ...



• 2007.19(3) The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)
  In addition to having anti-inflammatory activities, nonsteroidal anti-inflammatory drugs (NSAIDs) also inhibit neoplastic cell proliferation by inducing apoptosis. Diclofenac is the anti-neoplastic compound in diclofenac 3% gel (SolarazeTM) used for topical treatment of actinic keratosis (AK)...   |   Read more ...



• 2007.19(2) Apoptosis pathways as promising targets for skin cancer therapy
  Apoptosis pathways provide efficient safeguard mechanisms against cancer that are mediated via cell-intrinsic responses and immune-mediated extrinsic signals...   |   Read more ...



• 2007.19(1) Actinic keratoses: non-invasive diagnosis for field cancerisation
  Actinic keratoses (AKs) are among the most common cutaneous malignancies and have previously been classified as in situ squamous cell carcinoma (SCC) with reported progression rates of up to 20% over 10 years...   |   Read more ...

    Current Year Archive:   Dermatology News 2007   |   Main Archive:   Dermatology News  

The Derm News service provided by the Editorial Consultants of Skin Therapy Letter^© and its founding editor Dr. Stuart Maddin.